S1501 Carvedilol in Preventing Cardiac Toxicity in Patients With Metastatic HER-2-Positive Breast Cancer
Status: RECRUITING
Study type: INTERVENTIONAL
Conditions: Cardiotoxicity|HER2/Neu Positive|Metastatic Malignant Neoplasm in the Brain|Recurrent Breast Carcinoma|Stage IV Breast Cancer AJCC v6 and v7
Interventions: DRUG: Carvedilol|OTHER: Laboratory Biomarker Analysis|OTHER: Patient Observation
Sponsor: SWOG Cancer Research Network
Collaborators: National Cancer Institute (NCI)